We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ALISO VIEJO, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE:VRX) today announced that it will host a conference call and a live Internet webcast along with...
MAA successfully validated by EMEA ALISO VIEJO, Calif., Dec. 30 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE:VRX) today announced that the U.S. Food and Drug...
CHICAGO, Nov. 24 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for AIG, BIDU, PPG, JEF, and VRX. Seven Summits Strategic Investments' PriceWatch Alerts are available at...
ALISO VIEJO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE:VRX) today announced that results from the week-72 analysis for its Phase IIb dose-finding clinical trial for...
- Revenue up 31%, 45% at constant exchange rates - GAAP EPS $0.45, Cash EPS $0.58 - GAAP Cash Flow from Operations $52 million; Adjusted Cash Flow from Operations $65 million - Increased guidance...
-- Dr. LeWinn's is the highest selling skincare brand in Australian pharmacies -- Hissyfit and Revitanail/Renunail brands also included in acquisition ALISO VIEJO, Calif., Sept. 30...
-- U.S. submission expected on or before October 23, 2009 -- EMEA submission expected on October 30, 2009 -- Modified Release Phase I clinical study commencing in September ALISO VIEJO, Calif...
ALISO VIEJO, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE:VRX) today announced that J. Michael Pearson, the Company's chairman and chief executive...
Wife of Muhammad Ali Joins New Educational Campaign Supporting Parkinson's Disease Patients and Their Caregivers In the United States, 1.5 million Americans currently have Parkinson's disease...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.043 | 0.044 | 0.042 | 369515 | 0.0424462 | DE |
4 | -0.014 | -24.5614035088 | 0.057 | 0.058 | 0.042 | 538033 | 0.04774081 | DE |
12 | 0.008 | 22.8571428571 | 0.035 | 0.063 | 0.031 | 556860 | 0.04862371 | DE |
26 | 0.006 | 16.2162162162 | 0.037 | 0.063 | 0.026 | 433390 | 0.04223828 | DE |
52 | -0.067 | -60.9090909091 | 0.11 | 0.11 | 0.026 | 373580 | 0.05083559 | DE |
156 | -0.122 | -73.9393939394 | 0.165 | 0.225 | 0.026 | 313451 | 0.10665402 | DE |
260 | -0.056 | -56.5656565657 | 0.099 | 0.425 | 0.026 | 520829 | 0.17648601 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions